Monitoring swallowing and breathing in Parkinson’s disease patients with difficulty swallowing
DDT-COA-000167: Digital Sensor for Monitoring Swallow Count and Respiratory Coordination in Parkinson’s Disease patients with Dysphagia
This study is testing a new wireless device that helps track swallowing and breathing patterns in people with Parkinson's disease who have trouble swallowing, so they can get better care and support.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sibel INC. NIH-funded |
| Lab location | 1 site (Evanston, United States) |
| Project ID | NIH-11088667 on NIH RePORTER |
What this research studies
This research investigates a new wireless device designed to monitor swallowing and respiratory patterns in patients with Parkinson's disease who experience dysphagia. The device, known as the ADAM sensor, is placed at the suprasternal notch and utilizes advanced sensor technology and machine learning algorithms to provide continuous and accurate data on swallowing frequency and respiratory coordination. By addressing the limitations of current diagnostic tools, this project aims to enhance the management of dysphagia and related symptoms in real-life settings, ultimately supporting drug development and improving patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are Parkinson’s disease patients experiencing dysphagia and related respiratory issues.
Not a fit: Patients without Parkinson’s disease or those not experiencing swallowing difficulties are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better monitoring and management of swallowing difficulties in Parkinson’s disease patients, potentially reducing health complications and improving quality of life.
How similar studies have performed: Initial studies with the ADAM sensor have shown promise in effectively monitoring dysphagia and respiratory coordination in Parkinson’s disease patients, indicating potential for success in this approach.
Where this research is happening
Evanston, United States
- Sibel INC. — Evanston, United States (Active)
Researchers
- Principal investigator: Xu, Shuai — Sibel INC.
- Study coordinator: Xu, Shuai
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.